Cambridge Cognition offers advanced technology for accurate brain health assessment, backed by over 30 years of scientific research. Their digital cognitive assessments and decentralized clinical trials platform support CNS clinical trials and healthcare research.
Trusted by leading pharmaceutical organizations, research institutions, and healthcare professionals, Cambridge Cognition provides highly sensitive and accurate cognitive assessment technologies. These tools are used in clinical settings and at home, improving patient experience and accelerating drug development.
Connect to E-Prime offers a range of software and hardware solutions for integrating E-Prime with eye tracking, EEG, fNIRS, GSR, ECG, EMG, and TMS research, enhancing the capabilities of behavioral and physiological studies.
Focuses on research in the field of psychological development and education, covering the psychological development of children, adolescents, and adults.
The MEG Foundation for Pain is dedicated to advancing research and providing resources for better understanding and management of chronic pain, focusing on innovative treatments and therapies.